Literature DB >> 9257320

Corpus callosal changes associated with hydrocephalus: a report of two cases.

D Y Suh1, M Gaskill-Shipley, M W Nemann, R G Tureen, R E Warnick.   

Abstract

OBJECTIVE AND IMPORTANCE: Focal or diffuse corpus callosal changes can occur in patients with active hydrocephalus who undergo shunting procedures. The neural compression caused by active hydrocephalus and the conditions that follow ventricular shunting may contribute to the development of these changes. CLINICAL
PRESENTATION: Two patients who underwent successful shunting for hydrocephalus subsequently developed thickening and diffuse signal changes in the corpus callosum, which were revealed by magnetic resonance imaging. The abnormal signal intensity extended laterally and linearly along the callosal fiber tracts and was not associated with mass effect. These changes persisted despite clinical improvement after the shunts were implanted. INTERVENTION: Detailed neuropsychological testing showed no evidence of residual cognitive impairment or any interruption of the interhemispheric transfer of information. It has been proposed that the impingement of the corpus callosum by the rigid falx may contribute to symptomatic hydrocephalus. Impingement may cause partial hemispheric disconnection, resulting from callosal axonal dysfunction. Our patients showed radiographic evidence of dramatic changes within the corpus callosum after ventricular shunting, consistent with a transcallosal demyelinating process. Patients demonstrated neither clinical nor neuropsychological evidence of callosal disconnection, even though the callosal changes persisted. In these two patients, it is reasonable to assume that the relative sparing of the splenium accounts for the lack of neuropsychological deficits.
CONCLUSION: Based on our findings, conservative management, rather than a stereotactic biopsy or other forms of intervention, seems reasonable when these characteristic changes of the callosum are noted by magnetic resonance imaging after a shunt for hydrocephalus has been implanted in the patient.

Entities:  

Mesh:

Year:  1997        PMID: 9257320     DOI: 10.1097/00006123-199708000-00037

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Functional and magnetic resonance imaging correlates of corpus callosum in normal pressure hydrocephalus before and after shunting.

Authors:  Maria Mataró; Mar Matarín; Maria Antonia Poca; Roser Pueyo; Juan Sahuquillo; Maite Barrios; Carme Junqué
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

2.  Corpus callosum functioning in patients with normal pressure hydrocephalus before and after surgery.

Authors:  Maria Mataró; Maria Antonia Poca; Mar Matarín; Juan Sahuquillo; Nuria Sebastián; Carme Junqué
Journal:  J Neurol       Date:  2005-12-13       Impact factor: 4.849

Review 3.  [Corpus callosum. Landmark of the origin of cerebral diseases].

Authors:  E Hattingen; M Nichtweiss; S Blasel; F E Zanella; S Weidauer
Journal:  Radiologe       Date:  2010-02       Impact factor: 0.635

4.  Corpus callosal signal changes in patients with obstructive hydrocephalus after ventriculoperitoneal shunting.

Authors:  J I Lane; P H Luetmer; J L Atkinson
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

5.  MRI evaluation of pathologies affecting the corpus callosum: A pictorial essay.

Authors:  Aamish Z Kazi; Priscilla C Joshi; Abhimanyu B Kelkar; Mangal S Mahajan; Amit S Ghawate
Journal:  Indian J Radiol Imaging       Date:  2013-10

6.  White Matter Changes in Corpus Callosum in a Patient with Idiopathic Normal Pressure Hydrocephalus.

Authors:  Naresh Mullaguri; Anusha Battineni; Christopher R Newey; Premkumar Nattanmai
Journal:  J Neurosci Rural Pract       Date:  2017 Oct-Dec

7.  Corpus Callosum Swelling after Resection of Intraventricular Central Neurocytoma.

Authors:  Daiki Aburakawa; Masayuki Kanamori; Toshiaki Akashi; Shiho Sato; Ryuta Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.